Shareholder in Drug Co. Recordati Opposes €10.5B Bid
A minority stakeholder in Italian pharmaceutical giant Recordati SpA on Tuesday urged fellow shareholders not to accept a consortium's €10.5 billion ($11.8 billion) takeover offer, arguing the bid falls "far short"...To view the full article, register now.
Already a subscriber? Click here to view full article